Stroke is one of the most common killers in Indonesia, Malaysia and Singapore. The mortality rate due to stroke in Indonesia is around 192/100.000, 84/100.000 and 47.9/100.000 for Malaysia and Singapore respectively in last 5 years. Treatment time, cost and quality are believed as main factors contributing to high mortality and disability caused by stroke. This paper presents the relation between stroke management cost, mortality rate and disability rate in Indonesia, Malaysia and Singapore. We used stroke epidemiological data in Indonesia, Malaysia and Singapore for last 12 years. This includes stroke prevalence, incidence, mortality and disability. Normalized clinical pathway for stroke management is used to define cost, quality and treatment duration. Administration, imaging, diagnosis, medication, intensive care, in ward recovery and outpatient rehabilitation are parts in stroke management system. We consider also country specific Gross Domestic Product (GDP per capita) and percentage of national health expenditure to justify the stroke management cost level. All related factors contributed directly and indirectly to the cost are connected through relationship trees model. The model has been simulated to produce normalized country specific cost, mortality-prevalence ratio, and disability-prevalence ratio. Simulation results show that normalized country specific costs for stroke management each one day care are 2.52% for Malaysia, 0.65% for Singapore and 3.88% for Indonesia. Based on this cost, Malaysia is able to have mortality-prevalence ratio and disability-prevalence ratio of 0.12 and 2.11 respectively. As country with highest GDP per capita, Singapore has successfully managed to have 0.01 and 0.22 mortality-prevalence ratio and disability-prevalence ratio respectively. Indonesia, however, with stroke management cost higher than Malaysia, is only able to suppress the mortality-prevalence ratio up to 0.16 and disability-prevalence ratio up to 2.80. This shows that stroke management system in Indonesia needs to be improved.

1.
Feigin
VL
,
Forouzanfar
MH
,
Krishnamurthi
R
,
Mensah
GA
,
Connor
M
,
Bennett
DA
,
Moran
AE
,
Sacco
RL
,
Anderson
L
,
Truelsen
T
,
O’Donnell
M
,
Venketasubramanian
N
,
Barker-Collo
S
,
Lawes
CM
,
Wang
W
,
Shinohara
Y
,
Witt
E
,
Ezzati
M
,
Naghavi
M
,
Murray
C
;
Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group
.
Lancet
383
(
9913
),
245
254
(
2014
).
2.
World Health Organization
(
2018
).
The top 10 causes of death
[Online]. Available at: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. [Accessed: 17-May-2018].
3.
N.
Venketasubramanian
,
B. W.
Yoon
,
J.
Pandian
, and
J. C.
Navarro
.
J Stroke
19
(
3
),
286
294
(
2017
).
4.
Ministry of Health Indonesia
.
Indonesia Basic Health Research
(
Kementerian Kesehatan
,
Jakarta
,
2013
).
5.
Feigin
VL
,
Krishnamurthi
RV
,
Parmar
P
,
Norrving
B
,
Mensah
GA
,
Bennett
DA
,
Barker-Collo
S
,
Moran
AE
,
Sacco
RL
,
Truelsen
T
,
Davis
S
,
Pandian
JD
,
Naghavi
M
,
Forouzanfar
MH
,
Nguyen
G
,
Johnson
CO
,
Vos
T
,
Meretoja
A
,
Murray
CJ
,
Roth
GA
;
GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group
.
Neuroepidemiology
45
(
3
),
161
176
(
2015
).
6.
F.
Firmansyah
,
T. M.
Andayani
, and
R. T.
Pinzon
.
Journal of Management and Pharmacy Practice
6
,
8
(
2016
).
7.
S. Akhavan
Hejazi
,
M.
Mazlan
,
S.
Abdullah
, and
J.
Engkasan
.
Singapore Med J.
56
(
02
),
116
119
(
2015
).
8.
Muslimah
,
Tri Murti
Andayani
,
Rizaldy
Pinzon
, and
Dwi
Endarti
,
Journal of Management and Pharmacy Practice
7
(
2
),
105
114
(
2017
).
9.
J. S.
Iroth
,
R. A.
Ahmad
, and
R.
Pinzon
, “
Dampak Penerapan Clinical Pathway Terhadap Biaya Perawatan Pasien Stroke Iskemik Akut Di Rs Bethesda Yogyakarta
,” thesis,
Universitas Gadjah Mada
,
2016
.
10.
F. D.
Alexandra
,
I.
Dwiprahasto
, and
R.
Pinzon
.
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
45
(
02
),
61
70
(
2013
).
11.
Nor Azlin
MN
,
Syed Aljunid
SJ
,
Noor Azahz
A
,
Amrizal
MN
,
Saperi
S.
Med J Malaysia.
67
(
5
),
473
477
(
2012
).
12.
Cheah
WK
,
Hor
CP
,
Zariah
AA
,
Looi
I.
Med J Malaysia.
71
(
Suppl 1
),
58
69
(
2016
).
13.
N.
Venketasubramanian
and
A.
Yin
, “
Hospital Costs for Stroke Care in Singapore
,”
Cerebrovasc Dis
10
(
4
),
320
326
(
2000
).
14.
C. S.
Ng
,
M. P. H. S.
Toh
,
J.
Ng
, and
Y.
Ko
, “
Direct medical cost of stroke in Singapore
,”
International J S
10
(
SA100
),
75
82
(
2015
).
15.
R.
Pinzon
.
Jurnal Manajemen Pelayanan Kesehatan
12
(
4
), (
2009
).
16.
M.R.
Josoh
, “Consensus Statement on The Management of Ischaemic Stroke,”
1999
.
17.
Malaysian Society of Neurosciences, Academy of Medicine Malaysia, and Ministry of Health Malaysia. Clinical Practice Guideline: Management of Stroke (
Malaysian Society of Neurosciences
,
Malaysia
,
2012
).
18.
N.
Venketasubramanian
,
K. H.
Pwee
,
C. P. L.
Chen
, and
on behalf of the Singapore Ministry of Health Clinical Practice Guidelines Workgroup on Stroke and Transient Ischaemic Attacks
.
Int J S
6
(
3
),
251
258
(
2011
).
19.
College of Family Physicians Singapore, Academy of Medicine Singapore, Clinical Neuroscience Society Singapore, and Singapore National Stroke Association
, “Stroke and Transient Ischaemic Attacks: Assessment, Investigation, Immediate Management and Secondary Prevention.” (
Ministry of Health
,
Singapore
,
2009
).
20.
Saebo
(
2017
).
What Is The NIH Stroke Scale (NIHSS)?
[Online]. Available at: https://www.saebo.com/nih-stroke-scale-nihss/. [Accessed: 04-Jun-2018].
21.
J.
Misbach
and
W.
Ali
.
J Clin Neurosci.
8
(
3
),
245
249
(
2001
).
This content is only available via PDF.
You do not currently have access to this content.